请输入您要查询的百科知识:

 

词条 Phosphate binder
释义

  1. Medical use

  2. Adverse effects

  3. Choice of agent

     Types 

  4. Mechanism of action

  5. References

  6. External links

     Common Phosphate Binders 

Phosphate binders are medications used to reduce the absorption of phosphate and taken with meals and snacks. They are typically used in people with chronic kidney failure (CKF) as they often have difficulty getting rid of the phosphates that get into their blood (i.e., the serum phosphate in chronic kidney failure is typically elevated).

Medical use

For people with chronic kidney failure, controlling serum phosphate is important because it is associated with bone pathology and regulated together with serum calcium by the parathyroid hormone (PTH).{{ref|Lederer}}

They are also used in hypoparathyroidism which presents with hypocalcemia with hyperphosphatemia.

Adverse effects

With regard to phosphate binders, aluminium-containing compounds (such as aluminium hydroxide) are the least preferred because prolonged aluminium intake can cause encephalopathy and osteomalacia. If calcium is already being used as a supplement, additional calcium used as a phosphate binder may cause hypercalcemia and tissue-damaging calcinosis. One may avoid these adverse effects by using phosphate binders that do not contain calcium or aluminium as active ingredients, such as lanthanum carbonate or sevelamer.

Choice of agent

There have been limited trials comparing phosphate binders to placebo in the treatment of hyperphosphatemia in people with chronic kidney disease. When compared with people receiving calcium-based binders, people taking sevelamer have a reduced all-cause mortality.[1]

Types

Summary of Common Oral Phosphate Binders[2]
Phosphate Binder Brands Advantages Disadvantages
Aluminum salts Alucaps Calcium free Risk of aluminum toxicity
Basaljel High binder efficiency regardless of pH Requires frequent monitoring-extra cost
Cheap
Moderate tablet burden
Calcium carbonate Calcichew Aluminum free Calcium containing-potential risk of hypercalcemia and ectopic calcification
Titralac Moderate binding efficacy Parathyroid hormone oversuppression
Relatively low cost Gastrointestinal side effects
Moderate tablet burden Efficacy pH dependent
Chewable
Calcium acetate Lenal Ace Aluminum free Calcium containing-potential risk of hypercalcemia and ectopic calcification
PhosLo Higher efficacy than calcichew/sevelamer Parathyroid hormone oversuppression
Moderately cheap Gastrointestinal side effects
Lower calcium load than calcium carbonate Large tablets & capsules, nonchewable formulation
Sevelamer hydrochloride/Sevelamer carbonate Renagel Aluminium and calcium free Relatively costly
Renvela No gastrointestinal absorption High pill burden
Moderate efficacy Large tablets, nonchewable formulation
Reduces total and low-density lipoprotein cholesterol Gastrointestinal side effects
Binds fat-soluble vitamins
Lanthanum carbonate Fosrenol Aluminum and calcium free Relatively costly
Minimal gastrointestinal absorption Gastrointestinal side effects
High efficacy across full pH range
Chewable formulation
Palatable
Low tablet burden
Ferric CitrateAuryxiaIron basedVery costly
Tablets can be toxic to young children
Stool discoloration - may turn them black, obscuring intestinal bleeding
  • Calcium acetate/magnesium carbonate

Mechanism of action

These agents work by binding to phosphate in the GI tract, thereby making it unavailable to the body for absorption. Hence, these drugs are usually taken with meals to bind any phosphate that may be present in the ingested food. Phosphate binders may be simple molecular entities (such as magnesium, aluminium, calcium, or lanthanum salts) that react with phosphate and form an insoluble compound. Phosphate binders such as sevelamer may also be polymeric structures which bind to phosphate and are then excreted.

References

1. ^{{cite journal |last1=Patel |first1=L |last2=Bernard |first2=LM |last3=Elder |first3=GJ |title=Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials. |journal=Clinical Journal of the American Society of Nephrology |date=14 December 2015 |volume=11 |issue=2 |pages=232–244 |doi=10.2215/CJN.06800615 |pmid=26668024|pmc=4741042 }}
2. ^Burtis, C.A.; Ashwood, E.R. and Bruns, D.E. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5th Edition. Elsevier. pp1552
  1. {{note|Lederer}} Lederer E, Ouseph R, Erbeck K. Hyperphosphatemia, eMedicine.com, URL: http://www.emedicine.com/med/topic1097.htm, Accessed on July 14, 2005.
  2. {{note|Spiegel}} {{cite journal |doi=10.1053/j.jrn.2007.08.005|pmid=17971314|title=Magnesium Carbonate is an Effective Phosphate Binder for Chronic Hemodialysis Patients: A Pilot Study|journal=Journal of Renal Nutrition|volume=17|issue=6|pages=416|year=2007|last1=Spiegel|first1=David M.|last2=Farmer|first2=Beverly|last3=Smits|first3=Gerard|last4=Chonchol|first4=Michel}}

External links

  • [https://web.archive.org/web/20050924124247/http://fosrenol.com/Consumers/Default.aspx High Phosphate Control - Official Fosrenol Homepage]
  • Phosphate Binders: What Are They And How Do They Work? - American Association of Kidney Patients
  • Phosphate Binders - National Kidney Foundation
  • Phosphate Binders - Northwest Kidney Centers - a center that provides services for people with ESRD in the Seattle area.
  • High Phosphate - Phosphorus Control - Information for healthcare professionals on the treatment and management of hyperphosphatemia

Common Phosphate Binders

  • {{cite journal |doi=10.1093/ndtplus/sfr168|title=Use of magnesium as a drug in chronic kidney disease|journal=Clinical Kidney Journal|volume=5|pages=i62|year=2012|last1=Hutchison|first1=A. J.|last2=Wilkie|first2=M.}}
  • [https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a605015.html Lanthanum] - medlineplus.org
  • [https://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601248.html Sevelamer] - medlineplus.org
  • [https://www.aubagio.com/?s_mcid=AUWIKI001 Sevelamer] - Renvela.com
{{Drugs for treatment of hyperkalemia and hyperphosphatemia}}

2 : Phosphate binders|Nephrology procedures

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/20 8:43:18